Ozempic And Wegovy Overdose: Symptoms, Causes, Prevention

Accidental overdoses of semaglutide, the active ingredient in popular diabetes and weight-loss drugs

Ozempic

and

Wegovy

, have surged, primarily due to dosing errors with compounded versions of the medication. Poison control centers report increased calls, with symptoms ranging from severe nausea to hospitalization-requiring complications.

What Is Semaglutide and Why Is Overdose a Concern?

Semaglutide belongs to the

GLP-1 receptor agonist

class, mimicking a hormone that regulates blood sugar and appetite. Approved by the FDA as Ozempic for type 2 diabetes and Wegovy for obesity, it is typically self-administered via pre-filled pens with precise milligram doses.

However, high demand has led to compounded semaglutide—custom-made by pharmacies in vials requiring manual measurement with syringes. These lack FDA approval, varying in concentration and increasing overdose risks due to measurement confusion between units like milliliters (mL), milligrams (mg), and “units.”

The FDA has issued alerts on dosing errors causing overdoses, some severe enough for hospitalization. Semaglutide’s long half-life of about one week prolongs symptom duration, necessitating extended monitoring.

Causes of Semaglutide Overdoses

Overdoses stem mainly from user or provider errors with compounded products:

• Incorrect measurement: Patients unfamiliar with vials and syringes draw 10 times the intended dose, e.g., 0.5 mL instead of 0.05 mL.
• Unit confusion: Mixing mg, mL, and units; one provider prescribed 25 units instead of 5, delivering five times the dose.
• Unapproved sources: Drugs from compounding pharmacies or spas, potentially adulterated or impure.
• Lack of experience: Many patients new to injections miscalculate doses.

FDA-approved pens mitigate this by delivering fixed doses via simple clicks, unlike error-prone vials.

Symptoms of Ozempic or Wegovy Overdose

Overdose amplifies common side effects like nausea and vomiting into severe forms. Reported symptoms include:

• Severe, persistent

  nausea and vomiting

• **Abdominal pain and cramping**
• **Headache, dizziness, fatigue, and weakness**
• **Diarrhea and dehydration**
• Rare but serious:

  pancreatitis

  ,

  gastroparesis

  (stomach paralysis),

  intestinal obstruction (ileus)

  ,

  hypoglycemia

  (low blood sugar), fainting, migraines, and gallstones.

In case reports, a man experienced two days of vomiting and a week of nausea after a 10x overdose; a woman reported headache and fatigue. Some required ER visits.

Symptom	Common in Normal Doses	Severity in Overdose
Nausea/Vomiting	Mild-Moderate	Severe, unremitting; may last days
Abdominal Pain	Occasional	Intense cramping, potential pancreatitis
Headache/Dizziness	Rare	Persistent, with fatigue
Hypoglycemia	Uncommon	Severe low blood sugar

If symptoms exceed expected side effects, seek immediate medical help.

Real-Life Case Studies of Overdoses

Experts like Dr. Joseph Lambson, Director of the New Mexico Poison and Drug Information Center, documented cases in the Journal of the American Pharmacists Association.

• Case 1: 50-year-old man with type 2 diabetes injected 0.5 mL (10x intended 0.05 mL) from a compounding pharmacy vial. Suffered 2 days vomiting, 1 week nausea; no hospitalization.
• Case 2: 37-year-old woman administered 1 mL instead of 0.1 mL. Experienced persistent headache, weakness, fatigue; managed at home.
• Case 3: 33-year-old woman received suspected semaglutide at a spa; ER for nausea, vomiting, abdominal pain.
• FDA Examples: Provider errors led to 5-10x doses, causing severe vomiting in multiple patients.

These highlight vial-related risks over pens.

FDA Warnings and Guidance

The

FDA

urges caution with compounded semaglutide:

“Dosing errors have resulted from patients measuring and self-administering incorrect doses… and healthcare providers miscalculating doses.”

Recommendations:

• Use only FDA-approved Ozempic or Wegovy via prescription.
• Consult providers on vial dosing if compounded is necessary.
• Report adverse events to FDA MedWatch.
• Monitor for overdose symptoms due to prolonged effects.

What to Do If You Suspect an Overdose

1. Call poison control immediately: 1-800-222-1222 (nationwide, 24/7).
2. Contact your healthcare provider or go to the ER if symptoms are severe.
3. Provide details: dose amount, source, timing, symptoms.
4. Treatment is supportive: IV fluids for dehydration, anti-nausea meds; monitor for complications like pancreatitis.

Do not induce vomiting; professional care is essential.

Prevention Tips for Safe Semaglutide Use

Avoid overdoses by:

• Sticking to approved products: Pre-filled pens reduce errors.
• Double-checking doses: Use provider instructions; convert units accurately (e.g., confirm mg to mL).
• Starting low: Follow titration schedules to build tolerance.
• Educating yourself: Learn syringe markings; avoid unverified sources like spas.
• Monitoring blood sugar: Especially if diabetic, watch for hypoglycemia.

Frequently Asked Questions (FAQs)

What are the first signs of Ozempic overdose?

Severe nausea, vomiting, abdominal pain, headache, and dizziness that persist beyond normal side effects.

Can you overdose on FDA-approved Ozempic or Wegovy?

Rarely, as pens deliver fixed doses, but possible if misused. Compounded versions pose higher risks.

How long do overdose symptoms last?

Up to a week or more due to semaglutide’s long half-life; seek prompt treatment.

Is compounded semaglutide safe?

Not FDA-approved; lacks standardization, leading to frequent dosing errors and overdoses.

What should I do if I think I took too much semaglutide?

Call poison control at 1-800-222-1222 or go to the ER immediately.

The Bottom Line on Ozempic and Wegovy Safety

While semaglutide offers benefits for diabetes and weight management, overdose risks from compounded forms are rising. Prioritize FDA-approved sources, precise dosing, and quick action on symptoms to stay safe. Consult healthcare providers for personalized guidance amid ongoing shortages.